Basecamp Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4M Buy
14,478
+4
+0% +$4.09K 3.23% 4
2026
Q1
$13.3M Buy
14,474
+31
+0.2% +$31.4K 2.75% 7
2025
Q4
$15.5M Buy
+14,443
New +$13.8M 3.31% 5

Other funds holding LLY

Basecamp Wealth Advisors's LLY Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Eli Lilly (LLY) stake by 0.03% in Q2 2026, buying an estimated $4.09K and bringing the position to 14,478 shares worth $17.4M. The position accounts for 3.23% of the portfolio, ranked #4.

Basecamp Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,584 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Basecamp Wealth Advisors held 14,478 shares of Eli Lilly worth $17.4M as of Q2 2026.
  • Basecamp Wealth Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 3.23% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #4 holding.
  • Basecamp Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,584 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.